These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21892632)

  • 1. Radioprotection by the histone deacetylase inhibitor phenylbutyrate.
    Miller AC; Cohen S; Stewart M; Rivas R; Lison P
    Radiat Environ Biophys; 2011 Nov; 50(4):585-96. PubMed ID: 21892632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation protection and mitigation potential of phenylbutyrate: delivered via oral administration.
    Miller AC; Rivas R; McMahon R; Miller K; Tesoro L; Villa V; Yanushkevich D; Lison P
    Int J Radiat Biol; 2017 Sep; 93(9):907-919. PubMed ID: 28749244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL; Lee MY; Pui NN
    Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
    Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC inhibitor 4-phenylbutyrate preserves immature phenotype of human embryonic midbrain stem cells: implications for the involvement of DNA methyltransferase.
    Khan Z; Akhtar M; Ekström TJ
    Int J Mol Med; 2011 Dec; 28(6):977-83. PubMed ID: 21894430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
    Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
    Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of phenylbutyrate, a histone deacetylase inhibitor, on differentiation and apoptosis of Kasumi-1 cells].
    Hao CL; Tang KJ; Tian Z; Xing HY; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):241-4. PubMed ID: 12859874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
    Chang TH; Szabo E
    Clin Cancer Res; 2002 Apr; 8(4):1206-12. PubMed ID: 11948134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylbutyrate and β-cell function: contribution of histone deacetylases and ER stress inhibition.
    Khan S; Komarya SK; Jena G
    Epigenomics; 2017 May; 9(5):711-720. PubMed ID: 28470097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mouse bone marrow by Si-WU-Tang against whole body irradiation.
    Hsu HY; Ho YH; Lin CC
    J Ethnopharmacol; 1996 Jun; 52(2):113-7. PubMed ID: 8735456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs.
    Lea MA; Randolph VM; Hodge SK
    Anticancer Res; 1999; 19(3A):1971-6. PubMed ID: 10470142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
    Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
    Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor: antineoplastic agent and radiation modulator.
    Konsoula Z; Velena A; Lee R; Dritschilo A; Jung M
    Adv Exp Med Biol; 2011; 720():171-9. PubMed ID: 21901627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibition decreases preference without affecting aversion for nicotine.
    Pastor V; Host L; Zwiller J; Bernabeu R
    J Neurochem; 2011 Feb; 116(4):636-45. PubMed ID: 21166804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive hyperactivity of histone deacetylases enhances radioresistance in Lepidopteran Sf9 insect cells.
    Sharma K; Kumar A; Chandna S
    Biochim Biophys Acta; 2016 Jun; 1860(6):1237-46. PubMed ID: 26968462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice.
    Brown SL; Kolozsvary A; Liu J; Ryu S; Kim JH
    Radiat Res; 2008 Apr; 169(4):474-8. PubMed ID: 18363436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA protective properties of vanillin against gamma-radiation under different conditions: possible mechanisms.
    Maurya DK; Adhikari S; Nair CK; Devasagayam TP
    Mutat Res; 2007 Dec; 634(1-2):69-80. PubMed ID: 17644025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo radioprotection studies of 3,3'-diselenodipropionic acid, a selenocystine derivative.
    Kunwar A; Bansal P; Kumar SJ; Bag PP; Paul P; Reddy ND; Kumbhare LB; Jain VK; Chaubey RC; Unnikrishnan MK; Priyadarsini KI
    Free Radic Biol Med; 2010 Feb; 48(3):399-410. PubMed ID: 19931386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity.
    Gardian G; Yang L; Cleren C; Calingasan NY; Klivenyi P; Beal MF
    Neuromolecular Med; 2004; 5(3):235-41. PubMed ID: 15626823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.